|
Market Closed -
Nasdaq
21:00:00 23/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 87.73 USD | -2.01% |
|
+1.48% | +32.18% |
| 09-17 | Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating | MT |
| 09-16 | Dexcom Insider Sold Shares Worth $679,769, According to a Recent SEC Filing | MT |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 33,785 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 30.52% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 33,024 | 32,724 | 31,909 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 26% | -0.91% | -2.49% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 35.2x | 29.5x | 24.4x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 11.6x | 9.71x | 7.47x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.8x | 1.6x | 1.2x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 6.46x | 5.83x | 5.23x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 6.31x | 5.64x | 4.94x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 19.8x | 17x | 14.4x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 26.5x | 22.6x | 18.5x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 32.3x | 26.8x | 21.7x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.09% | 3.73% | 4.6% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.495 | 2.969 | 3.596 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,230 | 5,800 | 6,461 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,666 | 1,921 | 2,218 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,247 | 1,447 | 1,722 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 974.4 | 1,149 | 1,409 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -761.1 | -1,061 | -1,877 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 87.73 | 87.73 | 87.73 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 377,361 | - | - |
| Announcement Date | 10/02/22 | 09/02/23 | 08/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 35.89x | 6.31x | 19.82x | -.--% | 33.79B | |
| 29.38x | 4.05x | 15.66x | 2.48% | 179B | |
| 19.2x | 3.51x | 12.56x | 3.1% | 116B | |
| 17.22x | 0.2x | 12.61x | 0.76% | 60B | |
| 35.27x | 3.41x | 11.68x | 2.14% | 49.85B | |
| 27.56x | 6.78x | 17.54x | 1.45% | 48.05B | |
| 44.45x | 1.29x | 11.95x | 0.21% | 30.21B | |
| 43.27x | 7.59x | 27.23x | 0.24% | 26.12B | |
| 52.64x | 7.06x | 22.71x | 0.4% | 22.98B | |
| 17.57x | 2.66x | 9.48x | 1.66% | 20.98B | |
| Average | 32.24x | 4.29x | 16.12x | 1.25% | 58.75B | |
| Weighted average by Cap. | 28.73x | 3.93x | 15.17x | 1.85% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
